News

MedAdvisor Float

Pharmacists are being invited to become shareholders in the soon to publicly-list MedAdvisor, with proceeds from the float to be invested in consumer marketing initiatives to drive patients to pharmacies using the platform.

MedAdvisor has also recently committed to a “Patient Accelerate Program” giving pharmacists $1 for every patient signed to the system.  Data from existing MedAdvisor pharmacies shows patients are 97% loyal and 20% more adherent than those not using the system.

MedAdvisor CEO Robert Read said pharmacy customers would have priority status in the float and access to an ongoing 25% discount. See more at medadvisor.com.au/priority

Source:pharmacydaily.com.au, Wednesday 2 September 2015